Acyclovir Injection, Solution
NDC Package 70771-1384-6
Package Information
Acyclovir injection is classified as a
- dna polymerase inhibitors - [moa] (mechanism of action)
- herpes simplex virus nucleoside analog dna polymerase inhibitor - [epc] (established pharmacologic class)
- herpes zoster virus nucleoside analog dna polymerase inhibitor - [epc] (established pharmacologic class)
- herpesvirus nucleoside analog dna polymerase inhibitor - [epc] (established pharmacologic class)
- nucleoside analog - [ext]
Identification & Billing
- RxCUI: 1734932 - acyclovir sodium 500 MG in 10 ML Injection
- RxCUI: 1734932 - 10 ML acyclovir 50 MG/ML Injection
- RxCUI: 1734932 - 10 ML acycycloguanosine 50 MG/ML Injection
- RxCUI: 1734932 - acyclovir 50 MG/ML (equivalent to acyclovir sodium 54.9 MG/ML) per 10 ML Injection
- RxCUI: 1734932 - acyclovir 500 MG per 10 ML Injection
Clinical Specifications
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
Regulatory & Marketing
Hierarchy Structure
- 70771 - Zydus Lifesciences Limited
- 70771-1384 - Acyclovir
- 70771-1384-6 - 10 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE (70771-1384-1)
- 70771-1384 - Acyclovir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70771-1384-6 identifies a specific commercial package of 10 vial, single-use in 1 carton / 20 ml in 1 vial, single-use (70771-1384-1) of Acyclovir, a human prescription drug labeled by Zydus Lifesciences Limited. This injection, solution is formulated for intravenous use and contains acyclovir sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Lifesciences Limited on November 27, 2018. The current certification is valid through December 31, 2027.
How is this Zydus Lifesciences Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70771138406. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.